Table 3.
Correlation between demographic and clinical variables and the development of thrombotic events in thalassemic patients.
| Variable | No history of TE (n=33) | History of TE (n=7) | p-value |
|---|---|---|---|
| Gender (M/F) | 19/14 | 4/3 | 1.000¶ |
| Age (years) | 22 (20 – 26) | 20 (19 – 21) | .217§ |
| Type of thalassemia | .095# | ||
| Thalassemia minor | 5 (15.2%) | 0 (0.0%) | |
| Thalassemia intermedia | 19 (57.6%) | 3 (42.9%) | |
| Thalassemia major | 9 (27.3%) | 4 (57.1%) | |
| Splenectomy | 6 (18.2%) | 5 (71.4%) | .011¶ |
| Iron chelation therapy | 13 (39.4%) | 2 (28.6%) | .691¶ |
Data are ratio, median (interquartile range) or number (%).
¶Fisher’s exact test.
§Wilcoxon rank sum test.
#Chi-squared test for trend test.